-
Mercado's innovative antibiotic combination Recarbrio is approved by fda
Time of Update: 2020-06-09
today, the U.S FDA (http:// approved the listing of Recarbrio, an innovative antibiotic combination developed by the of Ms http:// to treat complex urinary tract infections (cUTI) and complex
-
Blueprint Medicines submits new drug application to FDA
Time of Update: 2020-06-09
recently, Blueprint Medicines (http:// announced that it had submitted a new drug (http:// application (NDA) for Avapritinib to the u.S FDA (http:// for the treatment of adult patients with
-
Four-ring medicine "non-PVC powder double chamber bag injection with cephalosporine sodium-sodium chloride injection" has been approved by the drug registration
Time of Update: 2020-06-09
recently, , the pharmaceutical (http:// of the Four Rings announced that the "non-PVC powder double chamber bag injection with cephalosporine sodium-sodium chloride injection" jointly developed by
-
AstraZeneca Bevespi Aerosphere (Grombrominam/Fumotro) has been approved by Japan
Time of Update: 2020-06-09
, AstraZeneca, the giant of Pharmaceuticals (http:// in the UK, announced that Bevespi Aerosphere had been approved in Japan as a fixed-dose, long-acting double bronchial dilatatator to relieve sy
-
Novo nornord recombinant coagulation factor VIII ."" (Turoctocog alfa) listed in China
Time of Update: 2020-06-09
recently, Novo Nordisk recombinant clotting factor VIII (Turoctocog alfa, trade name: Novoeight) was listed domestically for the treatment of type A haemophilia Previously, Zhengda Sun has complete
-
Teva Airduo ® Digihaler ™ inhaling powder gets FDA approval
Time of Update: 2020-06-09
recently, pharmaceutical (http:// giant Teva announced that the U.S Food and Drug (http:// Authority ( (http:// ) has approved airduo® Digihaler ™ (fluoroaticaso, 113 mcg/14 mcg) inhaled pow
-
EU approves Plynziq (pegvaliase injection) to reduce phenyl-amino in blood in people with phenyl-acetonuria
Time of Update: 2020-06-09
today, BioMarin Pharmaceutical company (http:// announced that the European Union has approved the launch of Peglynziq (pegvaliase injection) to reduce levels of phenylanine (Phe) in the blood of
-
AstraZeneca triple therapy Breztri Aerosphere gets MHLW approval for listing
Time of Update: 2020-06-09
COPD is an ongoing disease that can cause obstruction of air flow in the lungs and lead to degenerative breathing difficulties It affects the lives of 384 million people worldwide and is expected to
-
Roche releases new data on key research in haemophilia new drug Hemlizumab
Time of Update: 2020-06-09
, Swiss pharmaceutical (http:// giant Roche has released new data on key research by of the new drug (http:// of haemophili a At the meeting, Roche presented a total of 21 summaries from its h
-
FDA approves new drug market ingenues for Mercadobacteria therapy Zerbaxa (ceftolozane/tazobactam)
Time of Update: 2020-06-09
hospital acquired/respirator-related bacterial pneumonia (HABP/VABP) is a type of pneumonia that is susceptible to in-hospital and other medical (http:// institutions, and causes a variety of dif
-
Shandong Lu anti-dagli net film listing application to be accepted by CDE
Time of Update: 2020-06-09
news, recently, CDE accepted the Shandong Lu anti-dagli net film listing application, for China's first imitation products (http:// Daglenet Dapagliflozin was developed by Persimmon Squibb and
-
GlaxoSmithKline and Innoviva announce positive top results for new lung disease drug Trelegy Ellipta for asthma treatment
Time of Update: 2020-06-09
recently, British drugcompany GlaxoSmithKline (GSK) and partner Innoviva jointly announced the positive results of the critical phase III clinical study CAPTAIN (NCT02924688) for the treatment of as
-
State Drug Administration approves application for import registration of recombinant shingles vaccine (Singrix)
Time of Update: 2020-06-09
recently, the National Drug (http:// to approve the approval of the recombinant shingles vaccine (Singrix) import registration application for the prevention of shingles in adults 50 years and ol
-
Enzyvant's RVT-802 biologics license application accepted by the FDA and qualified for priority review
Time of Update: 2020-06-09
Today, The (http:// of the http:// company of Enzyvant Sciences , announced that it had accepted its biologic license application (BLA) for the of the research therapy RVT-802 the FDA (http:/
-
FDA approves the expansion of the heavy-duty drug Dupixent to extend indications
Time of Update: 2020-06-09
today, the FDA's (http:// announced that it has approved the expansion alphylopathy of the heavy- drug (http:// Dulumupi, developed jointly by Sanofi inc http:// and Regeneron, to treat adu
-
FDA accepts new drug application from Epizyme in research drug tazemetostat
Time of Update: 2020-06-09
epithelial sarcoma is a very rare soft tissue malignancies that occur mainly in young people aged 20-40 years, with a total survival period of about 30 months (OS) Today, Epizyme announced that FD
-
Keystone Pharmaceuticals CS1001 Joint BLU-554 (CS3008) therapy approved for clinical trials in China
Time of Update: 2020-06-09
recently, Cornerstone Pharmaceuticals (Suzhou) Limited Company (http:// announced that its CS1001 joint BLU-554 (CS3008) therapy for the treatment of localized advanced or metastatic hepatocellul
-
FDA approves Skyrizi (Risankizumab-rzaa) for treatment of moderate or severe plaque psoriasis
Time of Update: 2020-06-09
psoriasis is a common immune-related chronic inflammatory systemic disease At present, China has more than 6.5 million psoriasis patients, about 30% of the disease has developed to moderate to sever
-
Tafasitamab and Lenalidomide reach the main end of the trial in Phase 2 clinical trials treating Patients with DLBCL
Time of Update: 2020-06-09
DLBCL is the most common non-Hodgkin's lymphoma (NHL) type, accounting for 40% of B-cell NHL It is a rapidly moving NHL type 30-40% of patients did not respond to the initial therapy or relapsed re
-
NICE recommends Alnylam's Onpattro (patisiran) to treat multiple neuropathy caused by amyloid degeneration
Time of Update: 2020-06-09
The National Institute for Health and Clinical Excellence (NICE) has recently issued a positive opinion recommending http:// a drug (http:// http:// at the of the of Alnylam Pharmaceuticals (
